Dennis H. Giesing - May 28, 2021 Form 4 Insider Report for Immunome Inc. (IMNM)

Role
Chief Development Officer
Signature
/s/ Purnanand D. Sarma, Attorney-in-Fact
Stock symbol
IMNM
Transactions as of
May 28, 2021
Transactions value $
$0
Form type
4
Date filed
6/1/2021, 07:16 PM
Next filing
Jun 21, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IMNM Stock Option (Right to Buy) Award $0 +16.6K $0.00 16.6K May 28, 2021 Common Stock 16.6K $20.92 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of the shares subject to the option vest on May 28, 2022, and one-thirty-sixth (1/36th) of the remaining shares subject to the option shall vest every month thereafter.